Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Germany(1,798/week)
    • Poland(1,404/week)
    • France(1,170/week)
    • Spain(641/week)
    • Italy(357/week)
    • View all (9,157/week)
  • News
    • United States(561/week)
    • Manufacturing(389/week)
    • Energy(293/week)
    • Technology(380/week)
    • Other Manufacturing(333/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

Nasal administration

Jun 17, 2020
Mesa Science Associates and Bryn Pharma Publish Final of Three Pre-Clinical Studies of a New Approach to Treating Anaphylaxis
Apr 27, 2020
Mesa Science Associates and Bryn Pharma Publish Second Pre-Clinical Study of a New Approach to Treating Anaphylaxis
Mar 23, 2020
Biohaven to Advance Vazegepant into Phase 3 for the Acute Treatment of Migraine Following Successful End of Phase 2 Meeting with FDA
Jan 29, 2020
Dr. David Mahjoubi of Ketamine Healing Clinic Named 2020 Top Doctor by Los Angeles Magazine
Dec 09, 2019
Aptar’s Nasal Unidose Device Approved by U.S. FDA for First Nasal Rescue Treatment for Frequent Seizure Activity
Nov 20, 2019
Impel NeuroPharma Announces Publication Of Narrative Review In The Journal Headache Supporting Need For Novel Formulations Of Dihydroergotamine (DHE) In Addressing Acute Treatment Of Migraine
Nov 13, 2019
Mesa Science Associates and Bryn Pharma Announce Initial Study of a New Approach to Treating Anaphylaxis
Oct 17, 2019
Impel NeuroPharma Announces Appointment Of Diane Wilfong To Board Of Directors
Sep 05, 2019
Impel NeuroPharma to Present Data From INP104 Clinical Program at the 19th Congress of the International Headache Society
Sep 03, 2019
Satsuma Pharmaceuticals Announces Poster Presentations at the International Headache Congress
Sep 03, 2019
Impel NeuroPharma Announces Last Patient Enrolled In Phase 3 Trial Evaluating INP104 For The Treatment Of Acute Migraine
Jul 08, 2019
Satsuma Pharmaceuticals Announces Presentation of STS101 (Dihydroergotamine Nasal Powder) Phase 1 Trial Results at American Headache Society's Annual Scientific Meeting
Jun 26, 2019
FDA approves first treatment for chronic rhinosinusitis with nasal polyps
May 30, 2019
Kurve Technology Awarded Department of Defense (DOD) Contract
May 29, 2019
BlueWillow Biologics Announces Issuance of Intranasal Anthrax Vaccine Patent
Apr 30, 2019
Impel NeuroPharma To Present Data Highlighting Late-Stage Central Nervous System Pipeline At 2019 American Academy Of Neurology Meeting
Apr 01, 2019
Study Finds Vast Differences In Ease-Of-Use For Naloxone Delivery Methods
Mar 19, 2019
Aptar Pharma’s Bidose Nasal Drug Delivery Device Approved by U.S. FDA for Breakthrough Treatment of Depression
Jan 08, 2019
Dr. David Mahjoubi Of The Ketamine Healing Clinic Of L.A. Named 2019 Top Doctor By Los Angeles Magazine
Jan 07, 2019
Harebrained Approach To Treating Depression With Horse Tranquilizer Turns 10 Years Old
  •  
  • Page 1
  • ››

Latest News

Feb 7, 2023

HOUSTEX 2023 Speakers Provide Real-World Solutions to Manufacturing Technology Adoption and Business Practices

Feb 7, 2023

HighGround Strengthens Its Florida Footprint With The Acquisition of Expert Water Removal

Feb 7, 2023

ESAB Corporation Schedules Fourth Quarter 2022 Earnings Release and Conference Call

Feb 7, 2023

Nodal Exchange achieves January trading records in power and environmental markets

Feb 7, 2023

Gallium Semiconductor Unveils Cutting-Edge Manufacturing Facility in the Philippines

Feb 7, 2023

Grupo Saesa and Trilliant Sign Strategic, Long-Term Partnership

Feb 7, 2023

Tachyum Unveils Air Defense Superiority Using Prodigy AI White Paper

Feb 7, 2023

Pluglink Signs KRW 15 billion EV Charger Assets Investment Agreement with KDB KIAMCO

View all News

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2023 EPICOS
Made by Wedia